Literature DB >> 11598983

Natural rubber latex-related occupational asthma: association with interventions and glove changes over time.

G M Liss1, S M Tarlo.   

Abstract

BACKGROUND: Exposure to natural rubber latex (NRL) has been recognized as a cause of occupational asthma (OA), especially among health care workers (HCWs) associated with use of gloves. Little or no population-based data are available which chart the changes over time in the number of cases of OA as this problem was increasingly recognized and then interventions instituted.
METHODS: We obtained the numbers of allowed asthma claims with exposure to latex by year in the province of Ontario, Canada from the Ontario Workplace Safety and Insurance Board; details of the cases from the largest teaching hospital were reviewed. Interventions included: (1) in 1996, the Board recommended in its focus for accommodation of sensitized workers, the reduction of aerosols of latex proteins and that hospital facilities use powder-free, low-protein or nonlatex gloves; and (2) hospitals instituted latex policies and glove changes at various dates. For example, at the largest teaching hospital, interventions included education and voluntary medical surveillance in 1994; substitution of low protein, "powder-free" NRL gloves for non-sterile powdered gloves in 1995; and replacement of powdered sterile NRL gloves by lower protein, "powder-free" NRL gloves in 1997.
RESULTS: Through 1999, there were 60 allowed claims for asthma in Ontario with exposure to latex; of these 49 (82%) were among HCWs. The number of claims among HCWs changed from 0 to 2 per year up to 1990; increased to 7 to 11 per year between 1991-1994; and declined to 3 per year in 1995-1996 and 1 to 2 per year in 1997-1999. Of the ten institutions having two or more OA latex claims, all claims occurred in 1996 or earlier at 8 (80%). At the largest hospital, there were five accepted claims with year of diagnosis in 1993 (1 case), 1994 (3 cases), and 1995 (1 case).
CONCLUSIONS: These findings suggest that, despite the effect of increasing recognition, the introduction of gloves with reduced powder and/or protein, as well as other interventions have been associated temporally with declines in the number of cases of latex OA. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11598983     DOI: 10.1002/ajim.1108

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  6 in total

Review 1.  Prevention of occupational asthma.

Authors:  Susan M Tarlo; Gary M Liss
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

Review 2.  Primary prevention of latex related sensitisation and occupational asthma: a systematic review.

Authors:  A D LaMontagne; S Radi; D S Elder; M J Abramson; M Sim
Journal:  Occup Environ Med       Date:  2006-02-09       Impact factor: 4.402

3.  Effectiveness of a nationwide interdisciplinary preventive programme for latex allergy.

Authors:  Ute Latza; Frank Haamann; Xaver Baur
Journal:  Int Arch Occup Environ Health       Date:  2005-05-11       Impact factor: 3.015

4.  Opportunities and obstacles in translating evidence to policy in occupational asthma.

Authors:  Susan M Tarlo; Ahmed A Arif; George L Delclos; Paul Henneberger; Jenil Patel
Journal:  Ann Epidemiol       Date:  2017-03-31       Impact factor: 3.797

Review 5.  A brief targeted review of susceptibility factors, environmental exposures, asthma incidence, and recommendations for future asthma incidence research.

Authors:  Karin Yeatts; Peter Sly; Stephanie Shore; Scott Weiss; Fernando Martinez; Andrew Geller; Philip Bromberg; Paul Enright; Hillel Koren; David Weissman; MaryJane Selgrade
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

6.  The prevalence of latex sensitisation and allergy and associated risk factors among healthcare workers using hypoallergenic latex gloves at King Edward VIII Hospital, KwaZulu-Natal South Africa: a cross-sectional study.

Authors:  Shumani Makwarela Phaswana; Saloshni Naidoo
Journal:  BMJ Open       Date:  2013-12-09       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.